Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 29, 2017
Pharmacy Choice - News - Generic Drugs - May 29, 2017

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 48     Next >>     Go To Page:

5/28/17 - 5 Top NASDAQ Biotech Stocks: Nutraceutical Gained 48.93 Percent
Last week the Congressional Budget Office revealed the GOP replacement to Obamacare would end up nixing insurance coverage to 26 million american citizens by 2026 in an attempt to reduce $119 billion over the next decade. FDA head Scott Gottlieb announced it would remove the federal hiring freeze to his agency. Nutraceutical CytRx MannKind MEI Phar
5/28/17 - Purchase Along With The Delivery Of Oncological Drugs, Generic Drugs And Nutrition For The Hospital Pharmacy Of The Swietokrzyskie Center Of Oncology In Kielce. [TendersInfo (India)]
Contract notice: Purchase along with the delivery of oncological drugs, generic drugs and nutrition for the hospital pharmacy of the Swietokrzyskie center of oncology in kielce. Detailed description of the object of the order together with specification of assortment, quantity and quality requirements falling within the scope of the subject of...
5/27/17 - Attorney General Becerra Announces $33M Nationwide Settlement After Maker of Tylenol, Motrin, Benadryl Produced Adulterated Medicine
California Attorney General Xavier Becerra issued the following news release:. California Attorney General Xavier Becerra announced a $33 million settlement with drug manufacturer Johnson& Johnson after it violated federal regulations between 2009 and 2011 that ensure the quality of certain medicines, including many consumed by children.
5/27/17 - FDA panel backs Pfizer biosim to blockbuster anemia meds from Amgen, Johnson & Johnson [T-break Tech (Middle East)]
Pfizers biosimilar to blockbuster anemia meds Epogen and Procrit won the support of an FDA expert panel on Thursday, moving another step closer to a potential approval. Indeed, ahead of the panels meeting, FDA reviewers called the Pfizer med highly similar to the reference product, epoetin alfa, sold by Amgen as Epogen and Johnson& Johnson under th
5/27/17 - Glenmark gets USFDA`s approval to sell generic blood pressure medicine [Sudan Tribune]
Glenmark Pharmaceuticals today said it has received final approval from the US health regulator for its generic version Olmesartan Medoxomil Tablets, used in treatment of high blood pressure. The approval granted by the US Food and Drug Administration to Glenmark Pharmaceuticals Inc is for multiple strengths of 5 mg, 20 mg and 40 mg, the company sa
5/27/17 - Hogan lets drug price-gouging bill, dozens of others become law without signature [The Baltimore Sun]
Larry Hogan said Friday he will not block a new law giving the Maryland attorney general's office authority to take generic drug makers to court to challenge allegedly excessive price increases. The Republican governor's actions resolve the final questions surrounding the disposition of bills considered by the General Assembly in the 90- day sessio
5/27/17 - Intellipharmaceutics Files Preliminary Base Shelf Prospectus and Shelf Registration Statement to Replace Expiring Shelf Registration Statement [Sport360]
-Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that, in order to replace its existing expiring shelf registration statement, it has filed a new shelf registration...
5/27/17 - McCaskill, Collins Effort to Tackle Cost of Rx Drugs Clears Key Committee Hurdle
Claire McCaskill, D- Mo., issued the following news release:. A bipartisan plan from U.S. Senator Claire McCaskill and Republican Senator Susan Collins of Maine to combat the sudden, aggressive price hikes of generic drugs by promoting competition to help lower costs and improve accessibility cleared a key committee hurdle today and now advances to
5/27/17 - New FDA Commissioner reveals strategy to drive down drug prices [Tehran Times (Iran)]
According to Gottlieb, the FDA is currently working on a drug competition action plan which is designed particularly to accelerate the approval of generic drugs which face no competition. Gottlieb told a congressional panel that he aims for the FDA to take a more active role in the pricing of drugs, noting: While FDA does not play a direct role in
5/26/17 - Cosunter Pharmaceutical Viread Generic Drug Nodded
FUJIAN, May 26, SinoCast Reporters noticed that Fujian Cosunter Pharmaceutical Co., Ltd. has gotten registration approval for making generic drug of Viread curing HBV, since existing HBV drugs are facing risk for declining sales volume, dragging down net profit. In 2016, Cosunter Pharmaceutical harvested operating revenue climbing 1.28% from a ye
5/26/17 - FDA Panel Recommends Approval Of Epoetin Alfa Biosimilar Across All Indications
NEW YORK CITY- Pfizer Inc. said that the United States Food and Drug Administration Oncologic Drugs Advisory Committee recommended to approve Company's proposed epoetin alfa biosimilar across all indications. This marks the first time a biosimilar erythropoiesis-stimulating agent has been recommended for approval by a U.S. FDA Advisory Committee.
5/26/17 - Intellipharmaceutics Files Preliminary Base Shelf Prospectus and Shelf Registration Statement to Replace Expiring Shelf Registration Statement
Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that, in order to replace its existing expiring shelf registration statement, it has filed a new shelf registration...
5/26/17 - NINLARO Capsules Now Available for the Treatment of Multiple Myeloma in Japan
Release date- 24052017- Osaka, Japan- Takeda Pharmaceutical Company Limited today announced that NINLARO capsules are now available in Japan. NINLARO is the first oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone, for which Takeda has obtained the New Drug Application Approval for the treatment of patients with
5/26/17 - Pharmaceutical Packaging Equipment Market to Reach $8.24 Billion by 2022 - Driven by Growth in Funding For Generics & Biopharmaceutical Research - Research and Markets
Research and Markets has announced the addition of the "Pharmaceutical Packaging Equipment Market- Global Forecast to 2022" report to their offering. The global pharmaceutical packaging equipment market is projected to reach approximately USD 8.24 Billion by 2022 at an approximate CAGR of 6.8% during the forecast period. The growth of the pharmaceu
5/26/17 - Studies in the Area of Social and Administrative Pharmacy Reported from Faculty of Pharmacy (Translation and validation of the Arabic version of...
Studies in the Area of Social and Administrative Pharmacy Reported from Faculty of Pharmacy. By a News Reporter-Staff News Editor at Drug Week Data detailed on Drugs and Therapies- Social and Administrative Pharmacy have been presented. According to news reporting from Irbid, Jordan, by NewsRx journalists, research stated, "Generic drugs are cons
5/26/17 - Switzerlands Novartis to lift investment in medical research in SA [Syrian Arab News Agency]
Swiss drug manufacturer Novartis has signed a memorandum of agreement with the South African Medical Research Council and the department of science and technology that paves the way for the company to increase its investments in local medical research. In addition to its innovative drug business, it owns generic drug maker Sandoz and eye care unit
5/26/17 - Why biosimilars are changing the pharmaceutical industry
We caught up with Celltrion Healthcare's Ho-ung Kim to find out how biosimilars cut costs, increase access to medicine and are ultimately changing the industry?
5/25/17 - Eatontown drug execs will tell all in price-fixing case [Asbury Park Press, N.J.]
May 24 Two former drug company executives from Monmouth County reached a settlement and will cooperate with investigators in a price-fixing case against some of the nation's biggest generic drug makers, authorities said Wednesday. Jeffery Glazer and Jason Malek, who led Heritage Pharmaceuticals in Eatontown, agreed to provide documents, testimony
5/25/17 - FDA Advisory Committee Recommends Approval of Pfizer's Proposed Biosimilar to Epogen/Procrit Across All Indications
Pfizer Inc. today announced the United States Food and Drug Administration Oncologic Drugs Advisory Committee recommended approval of the Company s proposed epoetin alfa biosimilar across all indications. The Committee s recommendation reinforces the potential value of biosimilars in expanding access to additional high-quality treatment op
5/25/17 - Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR by Par Pharmaceutical [Tehran Times (Iran)]
-Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that its United States marketing partner, Par Pharmaceutical Inc., has launched the 10 and 20 mg strengthsof its generic...
5/25/17 - Julphar's Board of Directors Meeting Held on May 18th, 2017 [Mid-East.Info]
By 2020, the Emirati company aims to reach more than AED 2 billion sales and rank among the top 3 pharmaceutical companies in the UAE and in Saudi Arabia. Despite challenging market conditions and the overall regional situation that are impacting our industry, Julphar is consolidating its market share for the first Quarter, said Jerome Carle,
5/25/17 - Orchid Pharma gets US FDA approval for Aripiprazole tablet [Sudan Tribune]
Orchid Pharma Limited, in its BSE filing on Wednesday, announced that it has received Abbreviated New Drug Application approval from US FDA for Aripiprazole Tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg. Orchid Pharma Limited was trading at Rs 30.25, up by Rs 0.60 or 2.02%, on Wednesday, on the BSE. Orchid Pharma Ltd is currently trading
5/25/17 - States Have Reached Settlements, Cooperation Agreements With Two Former Drug Company Executives
New Jersey Attorney General Christopher S. Porrino issued the following news release:. Two former executives of a New Jersey- based generic pharmaceutical manufacturing company have entered into settlement and cooperation agreements with 41 states including New Jersey that are investigating what they allege is widespread anti-competitive activi
5/25/17 - Virginia, 40 Other States Reach Settlements, Cooperation Agreements with Two Former Executives in Generic Drug Multistate Investigation
Attorney General Mark R. Herring announced today that two former executives of a New Jersey- based generic pharmaceutical manufacturer have entered into settlement and cooperation agreements with 40 states that are investigating what they allege is widespread anticompetitive activity in the generic drug industry that has led to higher prices for...
5/24/17 - Dramatic increase in patient access across Europe [Sudan Tribune]
Medicines for Europe acknowledges the role of the European Commission and its partnership with QuintilesIMS in pursuing the dialogue and close monitoring of the unfolding competition in the biologics market. The new report on The Impact of Biosimilar Competition in Europe highlights the visible benefits of biosimilar competition to increase patient
Articles(s): 1 - 25 of 48     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415